Table 1.

Steady-state actin-activated ATPase measurements

Constructv0 (s−1)
(± SD)
ATPase @ 60 µM actin (s−1)
(± SD)
KATPase (µM)
(± SE)
kcat (s−1)
(± SE)
WT S1, n = 3 0.02 ± 0.01 3.8 ± 0.2 26.5 ± 5.6 5.7 ± 0.5 
WT 2HEP, n = 4 0.03 ± 0.03 3.4 ± 1.0 23.4 ± 11.5 4.7 ± 1.0 
WT 15HEP, n = 5 0.02 ± 0.02 0.4 ± 0.1 99.9 ± 64.5 1.1 ± 0.5 
WT 25HEP, n = 4 0.03 ± 0.02 0.6 ± 0.3 ND ND 
E525K S1, n = 3 0.04 ± 0.01 9.9 ± 1.4** 1.5 ± 0.6* 11.3 ± 0.5** 
E525K 2HEP, n = 3 0.03 ± 0.04 9.4 ± 0.3** 2.2 ± 0.8 9.5 ± 0.5* 
E525K 15HEP, n = 3 0.01 ± 0.02 0.2 ± 0.1* 53.3 ± 20.8 0.4 ± 0.1 
E525K 25HEP, n = 4 0.02 ± 0.02 0.7 ± 0.2 ND ND 
Constructv0 (s−1)
(± SD)
ATPase @ 60 µM actin (s−1)
(± SD)
KATPase (µM)
(± SE)
kcat (s−1)
(± SE)
WT S1, n = 3 0.02 ± 0.01 3.8 ± 0.2 26.5 ± 5.6 5.7 ± 0.5 
WT 2HEP, n = 4 0.03 ± 0.03 3.4 ± 1.0 23.4 ± 11.5 4.7 ± 1.0 
WT 15HEP, n = 5 0.02 ± 0.02 0.4 ± 0.1 99.9 ± 64.5 1.1 ± 0.5 
WT 25HEP, n = 4 0.03 ± 0.02 0.6 ± 0.3 ND ND 
E525K S1, n = 3 0.04 ± 0.01 9.9 ± 1.4** 1.5 ± 0.6* 11.3 ± 0.5** 
E525K 2HEP, n = 3 0.03 ± 0.04 9.4 ± 0.3** 2.2 ± 0.8 9.5 ± 0.5* 
E525K 15HEP, n = 3 0.01 ± 0.02 0.2 ± 0.1* 53.3 ± 20.8 0.4 ± 0.1 
E525K 25HEP, n = 4 0.02 ± 0.02 0.7 ± 0.2 ND ND 

*P < 0.05 or **P < 0.005 for comparison of E525K and WT, see Tables S1 and S2. The v0 and ATPase at 60 µM actin represent the mean (± SD) from n preparations. The KATPase and kcat are reported as ± SE from the fits of the data in Fig. 3.

or Create an Account

Close Modal
Close Modal